Login to Your Account



Financings Roundup

Indevus Closes $105M Note Deal Backed by Sanctura Royalties

By Trista Morrison


Wednesday, August 27, 2008
Indevus Pharmaceuticals Inc. joined the ranks of biotechs leveraging royalty streams to access nondilutive financing. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription